JP2023527049A5 - - Google Patents

Info

Publication number
JP2023527049A5
JP2023527049A5 JP2022572753A JP2022572753A JP2023527049A5 JP 2023527049 A5 JP2023527049 A5 JP 2023527049A5 JP 2022572753 A JP2022572753 A JP 2022572753A JP 2022572753 A JP2022572753 A JP 2022572753A JP 2023527049 A5 JP2023527049 A5 JP 2023527049A5
Authority
JP
Japan
Prior art keywords
sequence
fewer
residues
amino acid
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022572753A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023527049A (ja
Filing date
Publication date
Priority claimed from GBGB2007842.4A external-priority patent/GB202007842D0/en
Application filed filed Critical
Publication of JP2023527049A publication Critical patent/JP2023527049A/ja
Publication of JP2023527049A5 publication Critical patent/JP2023527049A5/ja
Pending legal-status Critical Current

Links

JP2022572753A 2020-05-26 2021-05-26 養子細胞療法に有用なポリペプチド Pending JP2023527049A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2007842.4 2020-05-26
GBGB2007842.4A GB202007842D0 (en) 2020-05-26 2020-05-26 Polypeptide useful in adoptive cell therapy
PCT/EP2021/064053 WO2021239812A1 (en) 2020-05-26 2021-05-26 Polypeptide useful in adoptive cell therapy

Publications (2)

Publication Number Publication Date
JP2023527049A JP2023527049A (ja) 2023-06-26
JP2023527049A5 true JP2023527049A5 (cg-RX-API-DMAC7.html) 2024-05-29

Family

ID=71406309

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022572753A Pending JP2023527049A (ja) 2020-05-26 2021-05-26 養子細胞療法に有用なポリペプチド

Country Status (9)

Country Link
US (1) US20230183311A1 (cg-RX-API-DMAC7.html)
EP (1) EP4157318A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023527049A (cg-RX-API-DMAC7.html)
CN (1) CN115955977A (cg-RX-API-DMAC7.html)
AU (1) AU2021279184A1 (cg-RX-API-DMAC7.html)
CA (1) CA3179441A1 (cg-RX-API-DMAC7.html)
GB (2) GB202007842D0 (cg-RX-API-DMAC7.html)
TW (1) TW202210503A (cg-RX-API-DMAC7.html)
WO (1) WO2021239812A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12227756B2 (en) 2018-04-18 2025-02-18 Ucl Business Ltd Engineered regulatory T cell
TW202321286A (zh) 2021-09-21 2023-06-01 英商圭爾醫療有限公司 抗p75ntr嵌合抗原受體
WO2023047100A1 (en) 2021-09-21 2023-03-30 Quell Therapeutics Ltd Anti-trem2 chimeric antigen receptor
GB202117298D0 (en) 2021-11-30 2022-01-12 Quell Therapeutics Ltd Signalling protein
US20250017967A1 (en) 2021-12-17 2025-01-16 Quell Therapeutics Limited Anti-thymocyte globulin for immunomodulation of a subject with regulatory t cells
EP4453022A1 (en) 2021-12-22 2024-10-30 Quell Therapeutics Limited Constitutive cytokine receptors
EP4496883A1 (en) 2022-03-22 2025-01-29 Quell Therapeutics Limited Methods and products for culturing t cells and uses thereof
EP4519294A1 (en) * 2022-05-04 2025-03-12 Earli Inc. Methods using surface-expressable activatable epitopes to localize and/or treat diseased cells
GB202217541D0 (en) 2022-11-24 2023-01-11 Quell Therapeutics Ltd Recombinant receptor
WO2024133472A1 (en) 2022-12-22 2024-06-27 Quell Therapeutics Limited Constitutive cytokine receptors
EP4403580A1 (en) 2023-01-23 2024-07-24 Medizinische Hochschule Hannover Anti-entpd3 chimeric antigen receptor
JP2026507781A (ja) 2023-01-23 2026-03-06 メディツィニシェ ホゥーシュル ハノーファー キメラ抗原受容体
CN120787258A (zh) 2023-02-07 2025-10-14 圭尔医疗有限公司 Treg细胞培养方法
WO2024175805A1 (en) 2023-02-24 2024-08-29 Medizinische Hochschule Hannover Chimeric antigen receptor
EP4420676A1 (en) 2023-02-24 2024-08-28 Medizinische Hochschule Hannover Chimeric antigen receptor
WO2024194355A1 (en) 2023-03-20 2024-09-26 Medizinische Hochschule Hannover Chimeric antigen receptor
EP4434539A1 (en) 2023-03-20 2024-09-25 Medizinische Hochschule Hannover Chimeric antigen receptor
WO2024194649A1 (en) 2023-03-22 2024-09-26 Quell Therapeutics Limited Engineered t cells and uses thereof
WO2024194642A1 (en) 2023-03-22 2024-09-26 Quell Therapeutics Limited Engineered t regulatory cell
EP4442322A1 (en) 2023-04-06 2024-10-09 Medizinische Hochschule Hannover Liver-specific car for use against immunologic rejection
CN121586727A (zh) 2023-06-21 2026-02-27 圭尔医疗有限公司 组成型细胞因子受体
EP4766382A1 (en) 2023-08-24 2026-07-01 Medizinische Hochschule Hannover BECAUSE FOR THE TREATMENT OF MS OR MA
EP4512415A1 (en) 2023-08-24 2025-02-26 Medizinische Hochschule Hannover Chimeric antigen receptor for treatment of multiple sclerosis or alzheimer's disease
US20260176598A1 (en) 2024-07-04 2026-06-25 Quell Therapeutics Limited Expression construct
EP4678187A1 (en) 2024-07-11 2026-01-14 Medizinische Hochschule Hannover Compound for use in the treatment of inflammatory bowel disease
WO2026027876A1 (en) 2024-07-29 2026-02-05 Quell Therapeutics Limited Chimeric antigen receptor
GB202411558D0 (en) 2024-08-06 2024-09-18 Quell Therapeutics Ltd Culture method

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE139900T1 (de) 1992-11-13 1996-07-15 Idec Pharma Corp Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
CA2528595A1 (en) 2003-06-13 2005-01-06 Oncomax Acquisition Corp. Preparation and application of anti-tumor bifunctional fusion proteins
US7700097B2 (en) 2003-06-27 2010-04-20 Biogen Idec Ma Inc. Purification and preferential synthesis of binding molecules
KR20080039844A (ko) 2005-05-24 2008-05-07 아베스타 겐그레인 테크놀로지스 피브이티 리미티드 B―세포 림프종 치료를 위한 cd20에 대한 모노클로날항체의 제조 방법
GB201206559D0 (en) 2012-04-13 2012-05-30 Ucl Business Plc Polypeptide
GB201415344D0 (en) * 2014-08-29 2014-10-15 Ucl Business Plc Protein
EP3250602A1 (en) * 2015-01-26 2017-12-06 Cellectis T cell receptor knock out engineered immune cells, endowed with chimeric antigen receptors binding to cd123 for the treatment of relapsed/refractory acute myeloid lymphoma or blastic plasmacytoid dendritic cell neoplasm
TWI700298B (zh) * 2015-04-13 2020-08-01 美商輝瑞股份有限公司 靶向b細胞成熟抗原之嵌合型抗原受體類
US10604586B2 (en) 2016-05-09 2020-03-31 Industrial Technology Research Institute Humanized monoclonal antibody and uses thereof
CN110869046B (zh) * 2017-03-31 2025-02-25 塞勒克提斯公司 通用型抗cd22嵌合抗原受体工程化的免疫细胞
MX2020010808A (es) * 2018-04-13 2021-03-02 Sangamo Therapeutics France Receptor de antigeno quimerico especifico para el receptor de interleucina-23.
CN112996819B (zh) * 2018-08-16 2025-11-04 纪念斯隆-凯特琳癌症中心 细胞分选系统及使用方法
GB201814203D0 (en) 2018-08-31 2018-10-17 King S College London Engineered regulatory t cell

Similar Documents

Publication Publication Date Title
GB2611448A (en) Polypeptide useful in adoptive cell therapy
AU2018298881B2 (en) Improved dual specificity polypeptide molecule
KR102174280B1 (ko) 키메라 항원 수용체
EP3472205B1 (en) Chimeric antigen receptor
AU2019205273B2 (en) Multi-domain immunomodulatory proteins and methods of use thereof
JP6936497B2 (ja) 多価Fv抗体
CA2811734C (en) Multimeric il-15 soluble fusion molecules and methods of making and using same
JP2022534680A5 (cg-RX-API-DMAC7.html)
JP2017527310A5 (cg-RX-API-DMAC7.html)
KR20220025698A (ko) 다기능 융합 단백질 및 이의 용도
CN111801347A (zh) Ctla-4变体免疫调节蛋白和其用途
JP2022545815A5 (cg-RX-API-DMAC7.html)
JP2024534783A5 (cg-RX-API-DMAC7.html)
RU2815388C2 (ru) Многофункциональные слитые белки и их применения
KR20260042160A (ko) 이중특이적 폴리펩티드 분자
WO2022026577A4 (en) Chimeric t cell receptors, nucleic acids, and methods of making and using the same
HK40003407B (en) Improved dual specificity polypeptide molecule
HK40003407A (en) Improved dual specificity polypeptide molecule
HK40029654B (en) Improved dual specificity polypeptide molecule
HK40029654A (en) Improved dual specificity polypeptide molecule
IL272045B2 (en) A polypeptide molecule with dual-purpose specificity